Cargando…
Responsiveness of the MOS-HIV and EQ-5D in HIV-infected adults receiving antiretroviral therapies
BACKGROUND: Selection of an appropriate patient-reported outcome (PRO) instrument for a clinical trial requires knowledge of the instrument’s responsiveness to detecting treatment effects. The purpose of this study was to examine the responsiveness of two health-related quality of life (HRQL) instru...
Autores principales: | Wu, Albert W, Hanson, Kristin A, Harding, Gale, Haider, Seema, Tawadrous, Margaret, Khachatryan, Alexandra, Pashos, Chris L, Simpson, Kit N |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3602001/ https://www.ncbi.nlm.nih.gov/pubmed/23497257 http://dx.doi.org/10.1186/1477-7525-11-42 |
Ejemplares similares
-
Patient reported outcome instruments used in clinical trials of HIV-infected adults on NNRTI-based therapy: a 10-year review
por: Simpson, Kit N, et al.
Publicado: (2013) -
Cost of Treatment in a US Commercially Insured, HIV-1–Infected Population
por: Solem, Caitlyn T., et al.
Publicado: (2014) -
Mapping MOS-HIV to HUI3 and EQ-5D-3L in Patients With
HIV
por: Joyce, Vilija R., et al.
Publicado: (2017) -
Mapping the medical outcomes study HIV health survey (MOS-HIV) to the EuroQoL 5 Dimension (EQ-5D-3 L) utility index
por: Shi, Yuan, et al.
Publicado: (2019) -
Adherence and Risk Behaviour in Patients with HIV Infection Receiving Antiretroviral Therapy in Bangkok
por: Clarke, Amanda, et al.
Publicado: (2012)